Discovery and SAR studies of novel 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cell line MDA-MB-468Jeyun Jo, Hwayoung Yun, Young‐Suk Jung et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 14